OBJECTIVE: Describe the functional, clinical and quality of life (QoL) profiles in patients with cervical dystonia (CD) with residual effect or without effect of botulinum toxin (BTX), as well as verify the existence of correlation between the level of motor impairment, pain and QoL. METHOD: Seventy patients were assessed through the Craniocervical dystonia questionnaire-24 (CDQ-24) and the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). RESULTS: The greater the disability, pain and severity of dystonia, the worse the QoL (p<0.0001). Greater severity relates to greater disability (p<0.0001). Pain was present in 84% of the sample, being source of disability in 41%. The most frequent complaints were: difficulty in keeping up with professional and personal demands (74.3%), feeling uneasy in public (72.9%), hindered by pain (68.6%), depressed, annoyed or bitter (47.1%), lonely or isolated (32.9%). CONCLUSION: The physical, social and emotional aspects are the most affected in the QoL of these patients.
OBJECTIVE: Describe the functional, clinical and quality of life (QoL) profiles in patients with cervical dystonia (CD) with residual effect or without effect of botulinum toxin (BTX), as well as verify the existence of correlation between the level of motor impairment, pain and QoL. METHOD: Seventy patients were assessed through the Craniocervical dystonia questionnaire-24 (CDQ-24) and the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). RESULTS: The greater the disability, pain and severity of dystonia, the worse the QoL (p<0.0001). Greater severity relates to greater disability (p<0.0001). Pain was present in 84% of the sample, being source of disability in 41%. The most frequent complaints were: difficulty in keeping up with professional and personal demands (74.3%), feeling uneasy in public (72.9%), hindered by pain (68.6%), depressed, annoyed or bitter (47.1%), lonely or isolated (32.9%). CONCLUSION: The physical, social and emotional aspects are the most affected in the QoL of these patients.
Authors: Cynthia L Comella; Susan H Fox; Kailash P Bhatia; Joel S Perlmutter; Hyder A Jinnah; Mateusz Zurowski; William M McDonald; Laura Marsh; Ami R Rosen; Tracy Waliczek; Laura J Wright; Wendy R Galpern; Glenn T Stebbins Journal: Mov Disord Clin Pract Date: 2015-04-06
Authors: M M Sperry; B M Kandel; S Wehrli; K N Bass; S R Das; P S Dhillon; J C Gee; G A Barr Journal: Neuroscience Date: 2017-04-06 Impact factor: 3.590
Authors: Hsin Fen Chien; Ana Lucia Zuma de Rosso; André Sobierajski Dos Santos; Carlos Roberto de Mello Rieder; Debora Palma Maia; Delson José da Silva; Marcio da Cunha Andrade; Marcus Vinicius Della Coletta; Maria do Desterro Leiros da Costa; Nasser Allam; Roberto César Pereira do Prado; Vanderci Borges; Vitor Tumas; Wagner de Goes Horta Journal: eNeurologicalSci Date: 2016-07-19
Authors: Tobias Ellermeyer; Karen Otte; Felix Heinrich; Sebastian Mansow-Model; Bastian Kayser; Axel Lipp; Adrian Seidel; Patricia Krause; Katharina Lauritsch; Elona Gusho; Friedemann Paul; Andrea A Kühn; Alexander U Brandt; Tanja Schmitz-Hübsch Journal: Mov Disord Clin Pract Date: 2016-03-24